Key result
Obesity correlated with the clinical severity of acute pancreatitis, whereas the presence of metabolic syndrome did not affect disease severity.
Why the study?
Does the presence of obesity and/or metabolic syndrome affect the clinical severity of acute pancreatitis in patients with acute pancreatitis?
Observational (n=140)
Does the presence of obesity and/or metabolic syndrome affect the clinical severity of acute pancreatitis in patients with acute pancreatitis?
Obesity, but not metabolic syndrome, correlates with the clinical severity of acute pancreatitis.
Answers are grounded in this paper and cite their sources.
Obesity was associated with acute pancreatitis severity in this cohort; leaves open metabolic syndrome's independent role and requires prospective validation.
OBJECTIVE: The incidence of acute pancreatitis (AP) is rising with increased prevalence of obesity, which exacerbates pancreatic injury. Metabolic syndrome (MS) is defined as a cluster condition of cardiovascular risk factors, including hyperglycemia, dyslipidemia, hypertension, and central obesity. We analyze if the presence of obesity and/or MS affects the course of pancreatitis. METHODS: Data were collected from 140 patients with AP between January 2010 and February 2013. Anthropometric data, including body mass index and waist circumference, were measured. Biochemical tests were used including fasting glucose, triglyceride, low- and high-density lipoprotein cholesterol levels, and total cholesterol level. Atlanta criteria, Acute Physiology and Chronic Health Evaluation II, and Ranson scoring system were used to define severe AP. Patients were classified as having MS based on the International Diabetic Federation criteria. RESULTS: The mean body mass index was 30.15 kg/m(2). Sixteen (11.4%) patients had severe AP, whereas 124 (88.6%) patients had mild AP. We found that 62.8% of patients with AP fulfilled the criteria of MS (P = 0.000). Body weight can be used to predict clinical severity of AP with significant P value (P = 0.009). CONCLUSIONS: The presence of MS in patients with pancreatitis is noticeable, but it does not affect the course of disease severity, whereas obesity correlates with pancreatitis severity.
No takes yet. Share an insight, caveat, or question.
Sawalhi et al. (2014) conducted an observational in Acute pancreatitis (n=140). Obesity and/or Metabolic Syndrome vs. Absence of obesity and/or metabolic syndrome was evaluated on Clinical severity of acute pancreatitis (p=0.009). Obesity correlated with the clinical severity of acute pancreatitis, whereas the presence of metabolic syndrome did not affect disease severity.
Synapse has enriched 10 related papers. Consider them for comparative context: